On the use of substandard medicines in hematology: An emerging concern in the Middle East and North Africa region

Mervat Mattar ¹, Collaborators of the NEtwork for Drug Quality and Safety (NEDQAS)

Collaborators

Collaborators of the NEtwork for Drug Quality and Safety (NEDQAS): Alaa F Alwan ², Houria Boukhelal ³, Zoubir Chouffai ⁴, Fadi Farhat ⁵, Mahmoud Hadipour ⁶, Emad Hamada ⁷, Mohamed Kadhim Jaffar ⁸, Mehran Karimi ⁹, Fawaz Al-Kasim ¹⁰, Hayder H Al-Momen ¹¹, Ahmad M Tarawah ¹², Atholl Johnston ¹³, Khaled M Musallam ¹⁴

Affiliations

¹Clinical Hematology Unit, Department of Internal Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt. Electronic address: mermattar770@gmail.com.

²National Center of Hematology and University College of Medicine, Baghdad, Iraq.

³University Hospital CHU Mustapha, Algiers, Algeria.

⁴Pediatric Oncology & Hematology Center, Casablanca, Morocco.

⁵Hammoud Hospital, Sidon, Lebanon.

⁶Iranian Thalassemia Society, Iran.

⁷Cairo University, Cairo, Egypt.

⁸Iraqi CML Patient Organization, Iraq.

⁹Hematology Research Center, Nemazee Hospital, Shiraz, Iran.

¹⁰King Saud Medical City, Riyadh, Saudi Arabia.

¹¹Al-Kindy College of Medicine, Baghdad University, Baghdad, Iraq.

¹²Madinah Blood Disorders Center, King Abdullah Medical City, Madinah, Saudi Arabia.

¹³Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

¹⁴International Network of Hematology, London, UK.

PMID: 29239738

DOI: 10.1016/j.ejim.2017.08.003

No abstract available

Keywords: Copy drugs; Hematology; Middle east; Substandard medicines.